ArticlePublisher preview availableLiterature Review

Molecular characterization of an imported dengue virus serotype 4 isolate from Thailand

Authors:
  • Yunnan Institute Of Parasitic Diseases
To read the full-text of this research, you can request a copy directly from the authors.

Abstract

The epidemic of dengue virus infections has spread markedly in Yunnan province of China in recent years due to an increase in the number of imported dengue cases. To the best of our knowledge, the present study is the first to report a whole genome sequence and molecular characterization of an imported DENV-4 isolate from Thailand. The current strain, 2013JH285, has an RNA genome of 10,772 nucleotides that shares 99.0% nucleotide and 99.7% amino acid sequence identity with the 2013 Thailand strain CTI2-13. Phylogenetic analysis of the whole genome sequence revealed that the 2013JH285 strain belongs to genotype I of DENV-4. Recombination analysis suggested that the 2013JH285 strain originated from inter-genotypic recombination of DENV-4 strains. The new complete DENV-4 genome sequence reported here might contribute to further understanding of the molecular epidemiology and disease surveillance of DENV-4 in China.
Vol.:(0123456789)
1 3
Archives of Virology (2018) 163:2903–2906
https://doi.org/10.1007/s00705-018-3906-7
ANNOTATED SEQUENCE RECORD
Molecular characterization ofanimported dengue virus serotype 4
isolate fromThailand
LingMo1,2· JiandongShi1,2,3· XiaofangGuo3· ZhaopingZeng1,2· NingzhuHu1,2,3· JingSun1,2,3· MeiniWu1,2,3·
HongningZhou3· YunzhangHu1,2,3
Received: 9 February 2018 / Accepted: 23 May 2018 / Published online: 14 June 2018
© Springer-Verlag GmbH Austria, part of Springer Nature 2018
Abstract
The epidemic of dengue virus infections has spread markedly in Yunnan province of China in recent years due to an increase
in the number of imported dengue cases. To the best of our knowledge, the present study is the first to report a whole genome
sequence and molecular characterization of an imported DENV-4 isolate from Thailand. The current strain, 2013JH285, has
an RNA genome of 10,772 nucleotides that shares 99.0% nucleotide and 99.7% amino acid sequence identity with the 2013
Thailand strain CTI2-13. Phylogenetic analysis of the whole genome sequence revealed that the 2013JH285 strain belongs
to genotype I of DENV-4. Recombination analysis suggested that the 2013JH285 strain originated from inter-genotypic
recombination of DENV-4 strains. The new complete DENV-4 genome sequence reported here might contribute to further
understanding of the molecular epidemiology and disease surveillance of DENV-4 in China.
Dengue is a widespread mosquito-borne viral disease caused
by dengue virus (DENV). Since 2010, the largest numbers
of dengue-related cases have been recorded in the Western
Pacific Region, Southeast Asia and Asian countries, closely
followed by the American region, while there is a relatively
low occurrence of the disease in the Eastern Mediterranean
region, Europe and Africa [1]. Approximately 390 million
dengue infections are estimated to occur annually worldwide
[2, 3]. The infected individuals tend to be young, with a
mean age of 30.1 years [1]. Thus, dengue imposes severe
disease and economic burden on both individuals and gov-
ernments of tropical and subtropical countries [2].
DENV possesses a 10.7-kb, linear, single-strand and
positive-sense RNA genome. It belongs to the genus Fla-
vivirus of the family Flaviviridae and has four known
distinguishable serotypes (DENV-1, DENV-2, DENV-3
and DENV-4). There is less epidemiological and com-
plete genome sequence information available for DENV-4
than for the other serotypes [4]. Nevertheless, population
genetics studies show that the re-emergence and increase
in DENV-4 frequency in the United States and Asian popu-
lations is influenced by the interaction of multiple factors
such as episodic positive selection, spatiotemporal distribu-
tion, and recombination [5, 6]. From 2010 to 2014, a total of
53,743 outbreak-associated dengue cases were documented
in China, of which 3.57% occurred in Yunnan province,
mainly between the months of August and November [7].
Geographically, Yunnan province is in southwest China and
borders with the dengue-endemic areas of Southeast Asian
countries [8]. Thailand is a highly DENV-4-endemic country
[9], and sporadic imported DENV-4 cases from Thailand
have been reported in Yunnan [10]. However, molecular
characterizations were only available for the viral E gene,
and the complete genome sequence of an imported DENV-4
isolate from Thailand is still lacking.
Handling Editor: Tim Skern.
Electronic supplementary material The online version of this
article (https ://doi.org/10.1007/s0070 5-018-3906-7) contains
supplementary material, which is available to authorized users.
* Hongning Zhou
zhouhn66@163.com
* Yunzhang Hu
huyunzhangym@126.com
1 Institute ofMedical Biology, Chinese Academy
ofMedical Sciences andPeking Union Medical College,
Kunming650118, China
2 Yunnan Key Laboratory ofVaccine Research
andDevelopment ofSevere Infectious Disease,
Kunming650118, China
3 Yunnan Provincial Key Laboratory ofVector-borne
Diseases Control andResearch, Yunnan Provincial Center
ofArborvirus Research, Yunnan Institute ofParasitic
Diseases, Pu’er665000, Yunnan, China
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
... 81,83 Genotype I has been established in Thailand for decades and has also spread to other countries. 86 However, genotype II was also detected in southern Thailand during 2015-2016. 81 The shifting of predominant serotypes in Thailand has been associated with crossprotective immunity and other immune alterations in the population, 87 and clade replacement has been postulated to result in improved viral fitness and increased transmissibility of the virus. ...
Article
Dengue poses a significant health and economic burden in the WHO South-East Asia Region. Approaches for control need to be aligned with current knowledge on the epidemiology of dengue in the region. Such knowledge will ensure improved targeting of interventions to reduce dengue incidence and its socioeconomic impact. This review was undertaken to describe the contemporary epidemiology of dengue and critically analyse the existing surveillance strategies in the region. Over recent decades, dengue incidence has continued to increase with geographical expansion. The region has now become hyper-endemic for multiple dengue virus serotypes/genotypes. Every epidemic cycle was associated with a change of predominant serotype/genotype and this was often associated with severe disease with intense transmission. Classical larval indices are widely used in vector surveillance and adult mosquito samplings are not implemented as a part of routine surveillance. Further, there is a lack of integration of entomological and disease surveillance systems, often leading to inaction or delays in dengue prevention and control. Disease surveillance does not capture all cases, resulting in under-reporting, and has thus failed to adequately represent the true burden of disease in the region. Possible solutions include incorporating adult mosquito sampling into routine vector surveillance, the establishment of laboratory-based sentinel surveillance, integrated vector and dengue disease surveillance and climate-based early warning systems using available technologies like mobile apps.
... Recombination is considered an important driver of viral evolution and adaption [34]. Numerous DENV recombinant events have been identified in previous studies [26,27,29,[34][35][36][37]. In this article, twenty recombinant isolates involving DENV1-4 were identified including each gene except 2K, and this was further conformed by the inconsistency of ML trees constructed with or without recombinant regions. ...
Article
Full-text available
Dengue fever, a mosquito-borne viral disease in humans, has been endemic in many Southeast Asian countries. Since its first outbreak in 1978 in Foshan, Guangdong province, China, dengue has been continually epidemic in recent years in Guangdong, which raised the concern whether dengue infection is endemic in Guangdong. In this study, we performed phylogenetic, recombinant, and nucleotide variation analyses of 114 complete genome sequences of dengue virus serotypes 1–4 (DENV1-4) collected from 2013 to 2017 in 18 of 21 cities of Guangdong. Phylogenetic analyses revealed that DENV sequences did not form a single cluster, indicating that dengue fever was not endemic in Guangdong, although DENV1-4 co-circulated in Guangdong. Twenty intra-serotype recombinant isolates involving DENV1-4 were detected, but no inter-serotype recombinant events were identified in this study. Additionally, the most recombinant events were detected simultaneously in the gene NS3 of DENV1-4. Nucleotide variation analyses showed that no significant intra-serotype differences were observed, whereas more significant inter-subtype differences were discovered in non-structural genes than in structural genes. Our investigation will facilitate the understanding of the current prevalent status of dengue fever in Guangdong and contribute to designing more effective preventive and control strategies for dengue infection.
Article
Full-text available
We present the latest version of the Molecular Evolutionary Genetics Analysis (MEGA) software, which contains many sophisticated methods and tools for phylogenomics and phylomedicine. In this major upgrade, MEGA has been optimized for use on 64-bit computing systems for analyzing bigger datasets. Researchers can now explore and analyze tens of thousands of sequences in MEGA. The new version also provides an advanced wizard for building timetrees and includes a new functionality to automatically predict gene duplication events in gene family trees. The 64-bit MEGA is made available in two interfaces: graphical and command line. The graphical user interface (GUI) is a native Microsoft Windows application that can also be used on Mac OSX. The command line MEGA is available as native applications for Windows, Linux, and Mac OSX. They are intended for use in high-throughput and scripted analysis. Both versions are available from www.megasoftware.net free of charge.
Article
Full-text available
This report is the first to characterise the complete coding sequence of a dengue virus serotype 4 (DENV-4) genotype I that was isolated from field-caught mosquitoes from an endemic area in Thailand in June 2013. The sequence was assembled from high-throughput sequencing reads generated by Illumina HiSeq. Three out of four observed intra-sample variants caused an amino acid variation in C, NS2B, and NS5 genes. The C4279T variant located in the NS2B gene can indirectly affect the proteolytic activity of the NS3 protein. The sequence provided in this study might be useful for the epidemiological study of DENV-4.
Article
Full-text available
Dengue is an arthropod-borne infectious disease caused by dengue virus (DENV) infection and transmitted by Aedes mosquitoes. Approximately 50–100 million people are infected with DENV each year, resulting in a high economic burden on both governments and individuals. Here, we conducted a systematic review and meta-analysis to summarize information regarding the epidemiology, clinical characteristics, and serotype distribution and risk factors for global dengue outbreaks occurring from 1990 to 2015. We searched the PubMed, Embase and Web of Science databases through December 2016 using the term “dengue outbreak.” In total, 3,853 studies were identified, of which 243 studies describing 262 dengue outbreaks met our inclusion criteria. The majority of outbreak-associated dengue cases were reported in the Western Pacific Region, particularly after the year 2010; these cases were primarily identified in China, Singapore and Malaysia. The pooled mean age of dengue-infected individuals was 30.1 years; of the included patients, 54.5% were male, 23.2% had DHF, 62.0% had secondary infections, and 1.3% died. The mean age of dengue patients reported after 2010 was older than that of patients reported before 2010 (34.0 vs. 27.2 years); however, the proportions of patients who had DHF, had secondary infections and died significantly decreased after 2010. Fever, malaise, headache, and asthenia were the most frequently reported clinical symptoms and signs among dengue patients. In addition, among the identified clinical symptoms and signs, positive tourniquet test (OR = 4.86), ascites (OR = 13.91) and shock (OR = 308.09) were identified as the best predictors of dengue infection, DHF and mortality, respectively (both P < 0.05). The main risk factors for dengue infection, DHF and mortality were living with uncovered water container (OR = 1.65), suffering from hypotension (OR = 6.18) and suffering from diabetes mellitus (OR = 2.53), respectively (all P < 0.05). The serotype distribution varied with time and across WHO regions. Overall, co-infections were reported in 47.7% of the evaluated outbreaks, and the highest pooled mortality rate (2.0%) was identified in DENV-2 dominated outbreaks. Our study emphasizes the necessity of implementing programs focused on targeted prevention, early identification, and effective treatment.
Article
Full-text available
The spread of dengue disease has become a global public health concern. Dengue is caused by dengue virus, which is a mosquito-borne arbovirus of the genus Flavivirus, family Flaviviridae. There are four dengue virus serotypes (1-4), each of which is known to trigger mild to severe disease. Dengue virus serotype 4 (DENV-4) has four genotypes and is increasingly being reported to be re-emerging in various parts of the world. Therefore, the population structure and factors shaping the evolution of DENV-4 strains across the world were studied using genome-based population genetic, phylogenetic and selection pressure analysis methods. The population genomics study helped to reveal the spatiotemporal structure of the DENV-4 population and its primary division into two spatially distinct clusters: American and Asian. These spatial clusters show further time-dependent subdivisions within genotypes I and II. Thus, the DENV-4 population is observed to be stratified into eight genetically distinct lineages, two of which are formed by American strains and six of which are formed by Asian strains. Episodic positive selection was observed in the structural (E) and non-structural (NS2A and NS3) genes, which appears to be responsible for diversification of Asian lineages in general and that of modern lineages of genotype I and II in particular. In summary, the global DENV-4 population is stratified into eight genetically distinct lineages, in a spatiotemporal manner with limited recombination. The significant role of adaptive evolution in causing diversification of DENV-4 lineages is discussed. The evolution of DENV-4 appears to be governed by interplay between spatiotemporal distribution, episodic positive selection and intra/inter-genotype recombination.
Article
Full-text available
In August 2013, Xishuangbanna, Yunnan Province, China, had its first dengue outbreak. Dengue virus (DENV) RNA detection in sera or viral isolates revealed that all 222 autochthonous patients detected and three Chinese travelers from Laos (imported cases) were positive for DENV-3 serotype, while DENV-1 and DENV-4 were detected in travelers from Myanmar and Thailand during the outbreak. For 33 suspected dengue cases collected before the outbreak, two imported cases from Laos and nine residents living in Laos (Laotian cases) were positive for DENV-3. Further, a random subset of 33 positive cases for DENV-3 was sequenced for the full envelope gene of DENV. Phylogenetic analysis showed that all of the 25 autochthonous cases sequenced were grouped into the same clade, genotype II of DENV-3, with imported cases from Laos and Laotian cases. These results suggest that the genotype II of DENV-3 was associated with the outbreak and may have originated from the virus circulating in Laos. © The American Society of Tropical Medicine and Hygiene.
Article
Full-text available
RDP4 is the latest version of recombination detection program (RDP), a Windows computer program that implements an extensive array of methods for detecting and visualising recombination in, and stripping evidence of recombination from, virus genome sequence alignments. RDP4 is capable of analysing twice as many sequences (up to 2,500) that are up to three times longer (up to 10 Mb) than those that could be analysed by older versions of the program. RDP4 is therefore also applicable to the analysis of bacterial full-genome sequence datasets. Other novelties in RDP4 include (1) the capacity to differentiate between recombination and genome segment reassortment, (2) the estimation of recombination breakpoint confidence intervals, (3) a variety of ‘recombination aware’ phylogenetic tree construction and comparison tools, (4) new matrix-based visualisation tools for examining both individual recombination events and the overall phylogenetic impacts of multiple recombination events and (5) new tests to detect the influences of gene arrangements, encoded protein structure, nucleic acid secondary structure, nucleotide composition, and nucleotide diversity on recombination breakpoint patterns. The key feature of RDP4 that differentiates it from other recombination detection tools is its flexibility. It can be run either in fully automated mode from the command line interface or with a graphically rich user interface that enables detailed exploration of both individual recombination events and overall recombination patterns.
Article
Full-text available
Dengue is a systemic viral infection transmitted between humans by Aedes mosquitoes. For some patients, dengue is a life-threatening illness. There are currently no licensed vaccines or specific therapeutics, and substantial vector control efforts have not stopped its rapid emergence and global spread. The contemporary worldwide distribution of the risk of dengue virus infection and its public health burden are poorly known. Here we undertake an exhaustive assembly of known records of dengue occurrence worldwide, and use a formal modelling framework to map the global distribution of dengue risk. We then pair the resulting risk map with detailed longitudinal information from dengue cohort studies and population surfaces to infer the public health burden of dengue in 2010. We predict dengue to be ubiquitous throughout the tropics, with local spatial variations in risk influenced strongly by rainfall, temperature and the degree of urbanization. Using cartographic approaches, we estimate there to be 390 million (95% credible interval 284-528) dengue infections per year, of which 96 million (67-136) manifest apparently (any level of clinical or subclinical severity). This infection total is more than three times the dengue burden estimate of the World Health Organization. Stratification of our estimates by country allows comparison with national dengue reporting, after taking into account the probability of an apparent infection being formally reported. The most notable differences are discussed. These new risk maps and infection estimates provide novel insights into the global, regional and national public health burden imposed by dengue. We anticipate that they will provide a starting point for a wider discussion about the global impact of this disease and will help to guide improvements in disease control strategies using vaccine, drug and vector control methods, and in their economic evaluation.
Article
Full-text available
Dengue virus serotype 4 (DENV-4) reemerged in Roraima State, Brazil, 28 years after it was last detected in the country in 1982. To study the origin and evolution of this reemergence, full-length sequences were obtained for 16 DENV-4 isolates from northern (Roraima, Amazonas, Pará States) and northeastern (Bahia State) Brazil during the 2010 and 2011 dengue virus seasons and for an isolate from the 1982 epidemic in Roraima. Spatiotemporal dynamics of DENV-4 introductions in Brazil were applied to envelope genes and full genomes by using Bayesian phylogeographic analyses. An introduction of genotype I into Brazil from Southeast Asia was confirmed, and full genome phylogeographic analyses revealed multiple introductions of DENV-4 genotype II in Brazil, providing evidence for >3 introductions of this genotype within the last decade: 2 from Venezuela to Roraima and 1 from Colombia to Amazonas. The phylogeographic analysis of full genome data has demonstrated the origins of DENV-4 throughout Brazil.
Article
Dengue fever/dengue haemorrhagic fever (DF/DHF) is the most important emerging viral disease affecting nearly half of the world's population. It is estimated that there are between 50 to 100 million cases of DF and about 500 000 cases of DHF which require hospitalization every year. In the WHO South-East Asia Region, over the past 15 years, DF/DHF has become a leading cause of hospitalization and death among children. The annual incidence of DF cases is estimated to be between 20-30 million and of DHF between 200 000 and 400 000 cases with 10 000 deaths. During 1996-1998, an increasing trend in morbidity associated with DF/DHF has been observed in India, Indonesia, Maldives, Myanmar, Sri Lanka and Thailand. There are formal DF/DHF control programmes in most of the countries except India and Maldives. The DF/DHF control strategy relies mainly on two aspects: (1) efficient disease management in hospitals to reduce case fatality rates, and (2) vector control through the integration of chemical, biological and environmental methods of control. Source reduction programmes are largely community-based, particularly utilizing schoolchildren. This presentation also details the role of the WHO